arrow
Back
N

Naval Daver

md anderson cancer center

89H-index
1.4KPaper Count
3.3WCitation Count
Published Papers 359
Publication Date
Clinical characteristics of secondary myeloid neoplasms in patients with inflammatory bowel disease
err2026-10-21
err0
PREAI
errTareq Abuasab; Shehab F. Mohamed; Hyunsoo Hwang; Xuemei Wang; Koji Sasaki; Musa Yilmaz; Tapan Kadia; Courtney DiNardo; Naval Daver; Naveen Pemmaraju; Farhad Ravandi; Hagop Kantarjian; Guillermo Garcia-Manero; Koichi Takahashi
errShare
errSave
An all-oral triplet regimen (decitabine/cedazuridine, venetoclax, and gilteritinib) for newly diagnosed and relapsed/refractory FLT3-mutated AML and high-risk MDS
err2026-10-13
err0
errOAAI
errRoberta S. Azevedo; Nicholas J. Short; Alex Bataller; Naval Daver; Tapan M. Kadia; Courtney DiNardo; Alexandre Bazinet; Ghayas Issa; Elias Jabbour; Gautam Borthakur; Jayastu Senapati; Wei-Ying Jen; Kelly Chien; Steven Kornblau; Dono Tippett; Musa Yilmaz; Guillermo Montalban-Bravo; Xuelin Huang; Wei Qiao; Hagop Kantarjian; Guillermo Garcia-Manero; Farhad Ravandi
errShare
errSave
Phase 1 dose escalation and expansion trial of the bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein SL-172154 (SIRPα-Fc-CD40L) in patients with higher-risk myelodysplastic syndrome or acute myeloid leukemia
errCancer
IF5.1
err2026-10-05
err0
errOAAI
errNaval G. Daver MD; Amer M. Zeidan MD; Anthony S. Stein MD; Joshua F. Zeidner MD; Keri Maher DO; Emily Curran MD; Dale Bixby MD, PhD; Wanxing Chai-Ho MD; Maximilian Stahl MD; Karen W. L. Yee MD; Don Stevens MD; Sawa Ito MD, PhD; Jana Reynolds MD; Patrick Medd MD, PhD; Emma Searle MD, PhD; Andrew Sochacki MD; Mary Lynn Savoie MD; Steven Green MD; Kazunobu Kato MD, PhD; Robert Hernandez PhD; Simon Metenou PhD; Bo Ma PhD; Lini Pandite MD; Taylor H. Schreiber MD, PhD; David A. Sallman MD
errShare
errSave
Outcomes of adult patients with Li-Fraumeni syndrome and myeloid neoplasms
errCancer
IF5.1
err2026-09-18
err0
errOAAI
errJayastu Senapati MD, DM; Hiam M. Abdel-Salam MS; Vladislav D. Jdanov MD; Sanam Loghavi MD; Ashley Woodson MS; Jessica Corredor MS; Gautam Borthakur MD; Naval G. Daver MD; Tapan M. Kadia MD; Koichi Takahashi MD, PHD; Yesid Alvarado MD; Naveen Pemmaraju MD; Uday R. Popat MD; Elizabeth J. Shpall MD; Farhad Ravandi MD; Florencia McAllister MD; Najat C. Daw MD; Guillermo Garcia-Manero MD; Banu K. Arun MD; Courtney D. DiNardo MD, MSCE
errShare
errSave
Clinical outcomes associated with NPM1 mutations in newly diagnosed acute myeloid leukemia
errCancer
IF5.1
err2026-08-13
err0
errOAAI
errAziz Farhat MD; Georgina El Hajjar MD; Hagop Kantarjian MD; Koji Sasaki MD, PhD; Nicholas J. Short MD; Branko Cuglievan MD; Sanam Loghavi MD; Keyur Patel MD, PhD; Alex Bataller MD, PhD; Wei Ying Jen MA, BMBCh, MRCP, MMed, FRCPath; Musa Yilmaz MD; Guillermo Montalban-Bravo MD; Danielle Hammond MD; Naveen Pemmaraju MD; Naval Daver MD; Farhad Ravandi MD; Elias Jabbour MD; Tapan Kadia MD; Gautam Borthakur MD; Guillermo Garcia-Manero MD; Courtney D. DiNardo MD; Ghayas C. Issa MD, MS
errShare
errSave
Tagraxofusp, azacitidine, and venetoclax in blastic plasmacytoid dendritic cell neoplasm
errBlood
IF23.1
err2026-07-08
err0
errOAAI
errAndrew A. Lane; Marlise R. Luskin; Julia Keating; Nicole R. LeBoeuf; Jacqueline S. Garcia; Shai Shimony; Rebecca Leonard; Adon Goodpaster; Theresa T. Nguyen; Ilene Galinsky; Ashleigh Eberly-Puleo; Naval Daver; Nitin Jain; Guillermo Garcia-Manero; Hagop Kantarjian; Marina Y. Konopleva; Anthony Stein; Naveen Pemmaraju
errShare
errSave
Microclone with megaimpact
errBlood
IF23.1
err2026-07-01
err0
PREAI
errSenapati, Jayastu; Daver, Naval G.
errShare
errSave
Prognostic and therapeutic implications of BRAF mutations in acute myeloid leukemia
errLeukemia
IF13.4
err2026-06-15
err0
errOAAI
errDarren Lee; Yazan Abu-Shihab; Kate Plas; Deedra Nicolet; Krzysztof Mrózek; Mark J. Routbort; Keyur P. Patel; Christopher J. Walker; Jill Buss; Andrew R. Stiff; Andrea Laganson; Courtney D. DiNardo; Naval G. Daver; Tapan M. Kadia; Farhad Ravandi; Andrew J. Carroll; Jonathan E. Kolitz; Bayard L. Powell; William G. Blum; Maria R. Baer; Guido Marcucci; Geoffrey L. Uy; Wendy Stock; Richard M. Stone; L. Jeffrey Medeiros; John C. Byrd; James S. Blachly; Robert L. Bowman; Jeffrey W. Tyner; Sanam Loghavi; Ann-Kathrin Eisfeld; Linde A. Miles
errShare
errSave
Long-Term Outcomes of Azacitidine, Venetoclax and Gilteritinib in Newly Diagnosed FLT3-Mutated AML
err2026-05-28
err0
errOAAI
errNicholas J. Short; Hagop Kantarjian; Naval Daver; Roberta S. Azevedo; Omer Karrar; Courtney D. DiNardo; Tapan Kadia; Musa Yilmaz; Manuel Maroun; Maria Hachem; Gautam Borthakur; Ghayas C. Issa; Elizabeth J. Shpall; Uday Popat; Xuelin Huang; Wei Qiao; Lewis Nasr; Walid Macaron; Regina Abramova; Guillermo Garcia-Manero
errShare
errSave
Prognostic impact of ASXL1 mutations in acute myeloid leukemia treated with lower intensity therapy
errCancer
IF5.1
err2026-05-06
err0
errOAAI
errJennifer Marvin-Peek MD; Courtney D. DiNardo MD, MSCE; Sanam Loghavi MD; Farhad Ravandi MD; Gautam Borthakur MD; Naval G. Daver MD; Tapan M. Kadia MD; Elias Jabbour MD; Andrew Dunbar MD; Guilin Tang MD, PhD; Nicholas J. Short MD; Fadi G. Haddad MD; Hussein A. Abbas MD, PhD; Eitan Kugler MD; Abhishek Maiti MD; Ghayas C. Issa MD; Koichi Takahashi MD, PhD; Kapil Bhalla MD; Naveen Pemmaraju MD; Yesid Alvarado MD; Elizabeth J. Shpall MD; Uday Popat MD; Jeremy Ramdial MD; Richard E. Champlin MD; Hagop M. Kantarjian MD; Guillermo Garcia-Manero MD; Jayastu Senapati MD, DM
errShare
errSave
Menin inhibitor DS-1594b drives differentiation and induces synergistic lethality in combination with venetoclax in acute myeloid leukemia cells with rearranged mixed-lineage leukemia and mutated nucleophosmin-1
err2026-05-01
err7
PREAI
errCiaurro, Valerio; Sharlandjieva, Vassilena; Skwarska, Anna; Chahrour, Catherine; Baran, Natalia; Zeng, Zhihong; Ramage, Cassandra; Daver, Naval; Carter, Bing Z.; Chaundhry, Sovira; Thandapani, Palaniraja; Martelli, Maria Paola; Milne, Thomas A.; Konopleva, Marina
errShare
errSave
Cladribine With Low-Dose Cytarabine and Venetoclax Alternating With Azacitidine and Venetoclax for Newly Diagnosed Acute Myeloid Leukemia
err2026-04-01
err0
PREAI
errKadia, Tapan M.; Bataller, Alex; Bazinet, Alexandre; Borthakur, Gautam; Daver, Naval; Short, Nicholas J.; DiNardo, Courtney; Jabbour, Elias; Rausch, Caitlin R.; Issa, Ghayas C.; Pemmaraju, Naveen; Ohanian, Maro; Maiti, Abhishek; Montalban-Bravo, Guillermo; Sasaki, Koji; Bouligny, Ian M.; Yilmaz, Musa; Haddad, Fadi G.; Masarova, Lucia; Chien, Kelly; Alvarado, Yesid; Jain, Nitin; Popat, Uday; Shpall, Elizabeth; Loghavi, Sanam; Qiao, Wei; Wang, Xuemei; Garcia-Manero, Guillermo; Ravandi, Farhad; Kantarjian, Hagop M.
errShare
errSave
Long-term outcomes in FLT3-mutated acute myeloid leukemia after frontline hypomethylating agent, venetoclax and a FLT3 inhibitor
err2026-04-01
err3
PREAI
errShort, Nicholas J.; Loghavi, Sanam; Yilmaz, Musa; Karrar, Omer; Kim, Kunhwa; DiNardo, Courtney D.; Kadia, Tapan M.; Maroun, Manuel; Borthakur, Gautam; Issa, Ghayas C.; Jabbour, Joseph; Oran, Betul; Shpall, Elizabeth J.; Popat, Uday; Patel, Keyur P.; Routbort, Mark; Konopleva, Marina; Ravandi, Farhad; Kantarjian, Hagop; Daver, Naval
errShare
errSave
Mutations in Isocitrate Dehydrogenase Portend a Poor Prognosis in Adult Patients with Acute Lymphoblastic Leukemia
err2026-03-24
err0
errOAAI
errHannah Goulart; Nicholas J. Short; Gautam Borthakur; Nitin Jain; Courtney DiNardo; Sanam Loghavi; Rita Khouri; Maria Hachem; Farhad Ravandi; Naval Daver; Tapan M. Kadia; Musa Yilmaz; Ghayas Issa; Alexandre Bazinet; Mahesh Swaminathan; Guillermo Montalban-Bravo; Fadi Haddad; Rebecca Garris; Hagop Kantarjian; Elias Jabbour
errShare
errSave
Overcoming Menin inhibitor resistance in AML cells with combinations including BET proteins and dual BRG1/BRM inhibitor
errBlood
IF23.1
err2026-02-26
err0
PREAI
errWarren Fiskus; Christopher P. Mill; Ghayas C. Issa; Jessica Piel; Mike Collins; Murphy Hentemann; Branko Cuglievan; Hanxi Hou; Antrix Jain; Anna Malovannaya; Tapan M. Kadia; Naval Daver; Koji Sasaki; Koichi Takahashi; Danielle Hammond; Jayastu Senapati; Sanam Loghavi; Lauren B. Flores; Xiaoping Su; Courtney D. DiNardo
errShare
errSave
BET inhibitor-based combinations targeting novel dependencies in MECOM-rearranged (r) AML
errLeukemia
IF13.4
err2025-12-19
err0
errOAAI
errChristine E. Birdwell; Warren Fiskus; Christopher P. Mill; Tapan M. Kadia; Naval Daver; Courtney D. DiNardo; Koji Sasaki; John A. Davis; Kaberi Das; Hanxi Hou; Antrix Jain; Anna Malovannaya; Lauren B. Flores; Rasoul Pourebrahim; Selina Yuan; Xiaoping Su; Michele Ceribelli; Kapil N. Bhalla
errShare
errSave
Correction: Long term results of venetoclax combined with FLAG-IDA induction and consolidation for newly diagnosed and relapsed or refractory acute myeloid leukemia
errLeukemia
IF13.4
err2025-12-10
err0
errOAAI
errCourtney D. DiNardo; Wei-Ying Jen; Koichi Takahashi; Tapan M. Kadia; Sanam Loghavi; Naval G. Daver; Lianchun Xiao; Patrick K. Reville; Ghayas C. Issa; Nicholas J. Short; Koji Sasaki; Sa A. Wang; Jillian K. Mullin; Sherry Pierce; Corey Bradley; Gautam Borthakur; Abhishek Maiti; Yesid Alvarado; Naveen Pemmaraju; Alessandra Ferrajoli; Mahesh Swaminathan; Maro Ohanian; Hussein A. Abbas; Danielle Hammond; Jan Burger; Fadi Haddad; Guillermo Montalban-Bravo; Kelly Chien; Lucia Masarova; Musa Yilmaz; Nitin Jain; Michael Andreeff; Guillermo Garcia-Manero; Steven Kornblau; Farhad Ravandi; Elias Jabbour; Marina Y. Konopleva; Hagop M. Kantarjian
errShare
errSave
Outcomes of Patients with IDH1-Mutated Myeloid Neoplasms Treated with Olutasidenib
err2025-12-10
err0
PREAI
errKelly S. Chien; Sanam Loghavi; Koji Sasaki; Deborah McCue; Naval G. Daver; Tapan M. Kadia; Farhad Ravandi; Nicholas J. Short; Ghayas C. Issa; Guillermo Montalban-Bravo; Fadi G. Haddad; Danielle E. Hammond; Mahesh Swaminathan; Alexandre Bazinet; Alex Bataller; Ian Bouligny; Sherry A. Pierce; Guillermo Garcia-Manero; Hagop M. Kantarjian; Courtney D. DiNardo
errShare
errSave
A phase 1/2 study of DS-1594 menin inhibitor in relapsed/refractory acute leukemias
err2025-11-27
err0
errOAAI
errJayastu Senapati; Marina Konopleva; Ghayas C. Issa; Elias Jabbour; Tapan Kadia; Courtney DiNardo; Gautam Borthakur; Naveen Pemmaraju; Nicholas J. Short; Musa Yilmaz; Indraneel Deshmukh; Joie Alvarez; Sanam Loghavi; Guilin Tang; Hussein A. Abbas; Michael Andreeff; Kapil Bhalla; Narasimha M. Midde; Nabil Said; Amy Noyalis; Derek E. Mires; Jing Ning; Lianchun Xiao; Farhad Ravandi; Guillermo Garcia-Manero; Hagop M. Kantarjian; Naval G. Daver
errShare
errSave
Optimizing lower intensity triplet therapy in acute myeloid leukemia: a practical guide
err2025-11-25
err0
errOAAI
errWei-Ying Jen; Curtis A. Lachowiez; Jennifer Marvin-Peek; Jessica K. Altman; Musa Yilmaz; Jacqueline S. Garcia; Yasmin Abaza; Nicholas J. Short; Joshua F. Zeidner; Naval G. Daver; Andrew H. Wei; Ghayas C. Issa; Courtney D. DiNardo
errShare
errSave